Skip to main content

Table 4 Univariate and multivariate analysis of the risk factors of moderate to severe post-ERCP pancreatitis

From: The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis

  Moderate to severe PEP
Univariate Multivariate
OR (95% CI) P OR (95% CI) P
Age < 50 3.10 (0.72–11.53) 0.098 3.60 (1.09–11.85) 0.035
Female 3.52 (0.77–16.11) 0.104   
P-duct manipulation 1.11 (0.35–3.51) 0.858   
Precut biliary EST 1.24 (0.39–3.91) 0.717   
Pancreatic EST 0.30 (0.04–2.34) 0.251   
ERPD 1.76 (0.52–5.92) 0.363 1.61 (0.46–5.59) 0.457
Nafamostat mesilate 0.32 (0.10–1.00) 0.051 0.30 (0.09–0.98) 0.047
  1. Multivariate analysis included variables with P-value < 0.1 in univariate analysis
  2. PEP post-ERCP pancreatitis, OR odds ratio, CI confidence interval, P-duct pancreatic duct, EST endoscopic sphincterotomy, EPBD endoscopic papillary balloon dilatation, ERPD endoscopic retrograde pancreatic drainage